Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism

Detalles Bibliográficos
Autores principales: Lucijanic, Marko, Krecak, Ivan, Soric, Ena, Sedinic, Martina, Sabljic, Anica, Derek, Lovorka, Jaksic, Ozren, Kusec, Rajko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629336/
https://www.ncbi.nlm.nih.gov/pubmed/34845183
http://dx.doi.org/10.1038/s41408-021-00585-2
_version_ 1784607185171382272
author Lucijanic, Marko
Krecak, Ivan
Soric, Ena
Sedinic, Martina
Sabljic, Anica
Derek, Lovorka
Jaksic, Ozren
Kusec, Rajko
author_facet Lucijanic, Marko
Krecak, Ivan
Soric, Ena
Sedinic, Martina
Sabljic, Anica
Derek, Lovorka
Jaksic, Ozren
Kusec, Rajko
author_sort Lucijanic, Marko
collection PubMed
description
format Online
Article
Text
id pubmed-8629336
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86293362021-11-30 Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism Lucijanic, Marko Krecak, Ivan Soric, Ena Sedinic, Martina Sabljic, Anica Derek, Lovorka Jaksic, Ozren Kusec, Rajko Blood Cancer J Correspondence Nature Publishing Group UK 2021-11-29 /pmc/articles/PMC8629336/ /pubmed/34845183 http://dx.doi.org/10.1038/s41408-021-00585-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Lucijanic, Marko
Krecak, Ivan
Soric, Ena
Sedinic, Martina
Sabljic, Anica
Derek, Lovorka
Jaksic, Ozren
Kusec, Rajko
Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
title Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
title_full Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
title_fullStr Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
title_full_unstemmed Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
title_short Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
title_sort thrombocytosis in covid-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629336/
https://www.ncbi.nlm.nih.gov/pubmed/34845183
http://dx.doi.org/10.1038/s41408-021-00585-2
work_keys_str_mv AT lucijanicmarko thrombocytosisincovid19patientswithoutmyeloproliferativeneoplasmsisassociatedwithbetterprognosisbuthigherrateofvenousthromboembolism
AT krecakivan thrombocytosisincovid19patientswithoutmyeloproliferativeneoplasmsisassociatedwithbetterprognosisbuthigherrateofvenousthromboembolism
AT soricena thrombocytosisincovid19patientswithoutmyeloproliferativeneoplasmsisassociatedwithbetterprognosisbuthigherrateofvenousthromboembolism
AT sedinicmartina thrombocytosisincovid19patientswithoutmyeloproliferativeneoplasmsisassociatedwithbetterprognosisbuthigherrateofvenousthromboembolism
AT sabljicanica thrombocytosisincovid19patientswithoutmyeloproliferativeneoplasmsisassociatedwithbetterprognosisbuthigherrateofvenousthromboembolism
AT dereklovorka thrombocytosisincovid19patientswithoutmyeloproliferativeneoplasmsisassociatedwithbetterprognosisbuthigherrateofvenousthromboembolism
AT jaksicozren thrombocytosisincovid19patientswithoutmyeloproliferativeneoplasmsisassociatedwithbetterprognosisbuthigherrateofvenousthromboembolism
AT kusecrajko thrombocytosisincovid19patientswithoutmyeloproliferativeneoplasmsisassociatedwithbetterprognosisbuthigherrateofvenousthromboembolism

Ejemplares similares